COVID-19 Ag
- UID
- IMP/IVD/2021/000365_2cbd6e3cdbc08bdab44f7eaa52b71bbc_323f34d346b674714999d5c35a031f36
- Device class
- Class C
- Brand name
- AFIAS ST2
- License holder
- BODITECH MED INDIA PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- AFIAS COVID-19 Ag is a fluorescence Immunoassay ( AFIAS ST2) for the qualitative detection of novel corona virus ( AFIAS ST2) in human nasopharyngeal swab. It is useful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of 'Novel Coronavirus' infection
COVID-19 Ag is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_2cbd6e3cdbc08bdab44f7eaa52b71bbc_323f34d346b674714999d5c35a031f36. This device is marketed under the brand name AFIAS ST2. The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.